Ra Medical Electrophysiology Division is Participating in EHRA Congress

Rhea-AI Summary

Ra Medical Systems (NYSE American:RMED) announced that its subsidiary, Catheter Precision, is participating in the European Heart Rhythm Association (EHRA) congress in Barcelona from April 16-18, 2023. This event features more than 4,100 members from the cardiology field and focuses on improving treatment for cardiac arrhythmias.

CEO David Jenkins highlighted the significance of the VIVO system, indicating its role in aiding ventricular ablations. Multiple abstracts showcasing VIVO were accepted for presentation at the conference, addressing key advancements in non-invasive electrophysiology and novel imaging techniques.

The VIVO system, which has received both FDA marketing clearance and CE mark, streamlines workflows in electrophysiology procedures by non-invasively identifying arrhythmia origins.

Positive

• Catheter Precision's participation in EHRA enhances visibility and credibility within the electrophysiology community.
• Multiple presentations on the VIVO system indicate strong clinical interest and acceptance.
• The VIVO system's FDA clearance and CE mark position it favorably in the medical device market.

Negative

• None.

FORT MILL, SC / ACCESSWIRE / April 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that its wholly owned subsidiary, Catheter Precision, Inc., participates in the European Heart Rhythm Association (EHRA). EHRA will take place in Barcelona, Spain from April 16-18. As a branch of the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA) is the leading network of European Cardiac Rhythm Management. The EHRA is a strong association with more than 4,100 members around the globe, including physicians, arrhythmologists, young electrophysiologists, nurses and allied professionals.

David Jenkins, CEO of Ra Medical Systems, said, "The acceptance of clinical science provides an opportunity for the EP community to come together and discuss ways to improve treatment of cardiac arrhythmias. Multiple abstracts from leading physicians is indicative of the important roll VIVO has in aiding ventricular ablations and signals clinical acceptance and adoption of VIVO among the community."

As previously announced, multiple submissions about Catheter Precision's VIVO system were accepted and will be presented at 2023 conference:

• Noninvasive electrophysiology vectricular mapping based on the equivalent double layer model: different workflows, same accuracy by Dr. Leonor Parreira (LaLuz Hospital, Lizbon, PRT), Prof Alejandro Jimenez Restrepo (Marshfield Clinic, Wisonsin, USA) and Prof Dacosta Antonie (CHU, ST Etienne, FRA) on the 16^th of April.
• Arm approach using VIVO/interprocedural vs outpatient by Prof Sabine Ernst (RBHT, London, GBR), on the 16^th of April.
• HD Grid Exit Point comparison with VIVO by Prof Tarv Dhanjal (UHCW, Coventry, GBR) of on the 17^th of April.
• Evaluation of novel electrocardiography imaging system to non-invasively predict PVC ablation sites by Dr Pocolo Marchese (Ospedale GC MAZZONI, Ascoli Piceno, ITA) on the 17^th of April.
• Bipolar ablation: first in man using combined robotic magnetic navigation with a manual approach in a complex PVC case by Prof Burkhard Huegl (Marienhaus Klinikim, Neuwied, DEU) on the 18^th of April.

About VIVO

Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. VIVO has received marketing clearance from the U.S. FDA and has the CE mark.

About Ra Medical Systems

Ra Medical, and its wholly owned subsidiary Catheter Precision, is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.

CONTACTS:

At the Company
David Jenkins
973-691-2000
mhuck@catheterprecision.com

SOURCE: Ra Medical Systems, Inc.

View source version on accesswire.com:
https://www.accesswire.com/749420/Ra-Medical-Electrophysiology-Division-is-Participating-in-EHRA-Congress

FAQ

What is the significance of Ra Medical's participation in the EHRA Congress 2023?

Ra Medical's participation in the EHRA Congress highlights its commitment to the electrophysiology community and the importance of its VIVO system in treating cardiac arrhythmias.

What presentations about the VIVO system are featured at EHRA 2023?

At EHRA 2023, several abstracts on the VIVO system are presented, focusing on non-invasive electrophysiology and innovative techniques for cardiac care.

What is the VIVO system developed by Catheter Precision?

VIVO is a non-invasive 3D imaging system that helps identify the origins of ventricular arrhythmias, streamlining workflows and reducing procedure times.

How does the VIVO system impact electrophysiology procedures?

VIVO's capabilities improve the efficiency of electrophysiology procedures by allowing for pre-procedural identification of arrhythmia origins.

What regulatory approvals does the VIVO system have?

The VIVO system has received marketing clearance from the U.S. FDA and holds a CE mark, confirming its safety and efficacy in the market.